Verastem (VSTM) Stock Analysis: AI Score & Alternative Data
VSTM alt-data: web traffic climbing, job postings lagging
Is Verastem a buy right now? The alternative data says hold. This VSTM stock analysis is built on the 25+ alternative data signals AltIndex tracks on Verastem every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 46/100: a Hold. The stock trades at $6.74 with a $519M market cap.
The bullish side of the 90-day ledger: web traffic up 66.0% to 13K monthly visits, headcount (according to LinkedIn) up 26.6% to 176 employees, and sentiment up 11.1% to 100/100. The drag: job postings down 60.0% to 6 open roles. That tension is what keeps the score mid-range.
VSTM’s broader alt-data profile also covers quarterly revenue ($20M), business outlook (68% of employees positive), X followers (3K), and Reddit mentions (1 a day). Every signal links to its own page with full history, the VSTM technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on VSTM is just below.
Verastem AI Stock Analysis
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for cancer. The company's core objective is to discover and develop innovative drugs that have the potential to improve patient outcomes significantly.
Analysis generated July 31, 2026.
Recent Verastem Stock Alerts
|
Verastem | August 7 Price is up by 9% in the last 24h. |
|
Verastem | August 7 Insider Alert: Paterson Dan is selling shares |
|
Verastem | July 31 Price is down by -6.4% in the last 24h. |
|
Verastem | July 29 Price is down by -6.1% in the last 24h. |
Verastem Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 13K | 66.0% | |
| Job Posts | 6 | 60.0% | |
| LinkedIn Employees | 176 | 26.6% | |
| Employee Recommend | 73 | 0% | |
| Business Outlook | 68 | 0% | |
| Sentiment | 100 | 11.1% | |
| Reddit Mentions | 1 | 0% | |
| X Mentions | 7 | 56.3% | |
| Stocktwits Mentions | 84 | 24.3% | |
| News Mentions | 1 | N/A | |
| Stocktwits Subscribers | 24K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 3K | 0% |
About Verastem (VSTM)
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
| Price | $6.74 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $519M |
| Year Range | $3 – $11 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Verastem News
View more →
RBC Capital Reaffirms Outperform Rating For Verastem (VSTM)July 15 - Yahoo Entertainment |
|
 |
Verastem Oncology’s pancreatic cancer combo shows 86% OS rateJune 17 - Biztoc.com |
 |
Verastem Stock Jumps As Data Shows Strong Survival Trends In Pancreatic CancerJune 17 - Biztoc.com |
 |
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 12 - Yahoo |
 |
Verastem Ends Lung Cancer Trial, Reallocates ResourcesJanuary 2 - Biztoc.com |
Verastem Earnings & Financial Performance
View all earnings →Verastem Insider Trading Activity
View all →| Paterson Dan filed to sell 589,940 shares at $0.0. Aug 3 '26 |
| Calkins Daniel filed to sell 117,238 shares at $0.0. Jun 22 '26 |
| Calkins Daniel filed to sell 117,295 shares at $0.0. Jun 22 '26 |
| Paterson Dan filed to sell 591,242 shares at $0.0. Jun 22 '26 |
| Paterson Dan filed to sell 612,113 shares at $0.0. May 4 '26 |
Verastem Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Verastem
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
OptheaOPT |
$3.41 7.2% | $525M | 46 |
 |
Prime MedicinePRME |
$3.08 4.4% | $533M | 57 |
 |
I-MabIMAB |
$4.63 0.2% | $534M | 45 |
 |
Sagimet BiosciencesSGMT |
$9.06 3.7% | $540M | 50 |
 |
Zura BioZURA |
$5.97 4.5% | $542M | 55 |
Explore Verastem Data
Frequently Asked Questions: Verastem (VSTM)
Verastem has an AltIndex AI Score of 46/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
46/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Verastem (VSTM) stock is $6.74 with a market cap of $519M.
As of today, Verastem’s PE (Price to Earnings) ratio is —.
View the latest Verastem insider transactions to see recent buying and selling activity by company executives and directors.
Check the Verastem congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The VSTM stock price chart above shows Verastem’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Verastem technical analysis for RSI, moving averages, and more.
See the stocks similar to Verastem section on this page for companies in the same industry ranked by market cap and AI Score.
